These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26501538)

  • 1. Optimizing Mammography Screening Intervals.
    Yi M; Hunt KK
    JAMA; 2015 Oct; 314(15):1635-6. PubMed ID: 26501538
    [No Abstract]   [Full Text] [Related]  

  • 2. Measuring the Effectiveness of Mammography.
    Chen WY
    JAMA Oncol; 2015 Nov; 1(8):1037-8. PubMed ID: 26501739
    [No Abstract]   [Full Text] [Related]  

  • 3. Integrated 2D and 3D mammography.
    Sumkin JH
    Lancet Oncol; 2013 Jul; 14(8):e292-3. PubMed ID: 23816295
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening mammography after autologous breast reconstruction is not beneficial.
    Barton MK
    CA Cancer J Clin; 2015; 65(1):3-4. PubMed ID: 25533748
    [No Abstract]   [Full Text] [Related]  

  • 5. Overdiagnosis in mammography screening: a 45 year journey from shadowy idea to acknowledged reality.
    Barratt A
    BMJ; 2015 Mar; 350():h867. PubMed ID: 25736426
    [No Abstract]   [Full Text] [Related]  

  • 6. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
    Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
    Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network.
    Lynge E; Ponti A; James T; Májek O; von Euler-Chelpin M; Anttila A; Fitzpatrick P; Frigerio A; Kawai M; Scharpantgen A; Broeders M; Hofvind S; Vidal C; Ederra M; Salas D; Bulliard JL; Tomatis M; Kerlikowske K; Taplin S;
    Eur J Cancer; 2014 Jan; 50(1):185-92. PubMed ID: 24041876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive values of BI-RADS(®) magnetic resonance imaging (MRI) in the detection of breast ductal carcinoma in situ (DCIS).
    Badan GM; Piato S; Roveda D; de Faria Castro Fleury E
    Eur J Radiol; 2016 Oct; 85(10):1701-1707. PubMed ID: 27666605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of organised mammography screening on stage-specific incidence in Norway: population study.
    Lousdal ML; Kristiansen IS; Møller B; Støvring H
    Br J Cancer; 2016 Mar; 114(5):590-6. PubMed ID: 26835975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
    Gangnon RE; Sprague BL; Stout NK; Alagoz O; Weedon-Fekjær H; Holford TR; Trentham-Dietz A
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):905-12. PubMed ID: 25787716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammorgraphy reporting at Tygerberg hospital, Cape Town, South Africa.
    Pitcher R; Lotz J; Ackermann C; Bagadia A; Davis R; du Plessis AM; Griffith-Richards S; Hattingh R; Wagener G
    S Afr Med J; 2014 Jul; 104(7):456. PubMed ID: 25298984
    [No Abstract]   [Full Text] [Related]  

  • 13. Case quiz. Intracystic papillary carcinoma of the breast.
    Muttarak M; Chaiwun B; Trakultivakorn H
    Australas Radiol; 2002 Mar; 46(1):129-31. PubMed ID: 11966605
    [No Abstract]   [Full Text] [Related]  

  • 14. StatBite: Percent change in DCIS, invasive breast cancer, and mammography.
    J Natl Cancer Inst; 2011 Mar; 103(6):457. PubMed ID: 21393608
    [No Abstract]   [Full Text] [Related]  

  • 15. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
    Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
    Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiodiagnosis of minimal breast cancer].
    Semiglazov VV; Krzhivitskiĭ PI
    Vopr Onkol; 2001; 47(1):99-102. PubMed ID: 11317549
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening mammography-detected ductal carcinoma in situ: mammographic features based on breast cancer subtypes.
    Kim MY; Kim HS; Choi N; Yang JH; Yoo YB; Park KS
    Clin Imaging; 2015; 39(6):983-6. PubMed ID: 26259866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does breast screening offer a survival benefit? A retrospective comparative study of oncological outcomes of screen-detected and symptomatic early stage breast cancer cases.
    Újhelyi M; Pukancsik D; Kelemen P; Kovács E; Kenessey I; Udvarhelyi N; Bak M; Kovács T; Mátrai Z
    Eur J Surg Oncol; 2016 Dec; 42(12):1814-1820. PubMed ID: 27424787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of digital screening mammography among older women in the United States.
    Henderson LM; O'Meara ES; Braithwaite D; Onega T;
    Cancer; 2015 May; 121(9):1379-86. PubMed ID: 25537958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computer-aided detection in mammography: downstream effect on diagnostic testing, ductal carcinoma in situ treatment, and costs.
    Fenton JJ; Lee CI; Xing G; Baldwin LM; Elmore JG
    JAMA Intern Med; 2014 Dec; 174(12):2032-4. PubMed ID: 25347134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.